Literature DB >> 23523576

Previous contact with Strongyloides venezuelensis contributed to prevent insulitis in MLD-STZ diabetes.

Raphael Sanches Peres1, Fernanda Chiuso-Minicucci, Larissa Camargo da Rosa, Alexandre Domingues, Sofia Fernanda Gonçalves Zorzella-Pezavento, Thais Graziela Donegá França, Larissa Lumi Watanabe Ishikawa, Alessandro Francisco Talamini do Amarante, Alexandrina Sartori.   

Abstract

Epidemiological and experimental studies support the idea that helminth infections can induce a protective effect against the development of autoimmune and allergic diseases. In this study we characterized the immune response induced by Strongyloides venezuelensis infection in C57BL/6 mice and then evaluated the effect of a previous contact with this helminth in the outcome of type 1 diabetes. Animals were initially infected with 2000 L3 larvae from S. venezuelensis and euthanized 22 days later. An acute phase, identified by a high amount of eggs per gram of feces, was established between days 7 and 9 post-infection. Recovery from infection was associated with a Th2 polarized response characterized by a significant level of serum IgG1 specific antibodies and also a significant production of IL-5 and IL-10 by spleen cells stimulated with S. venezuelensis soluble antigen. Immunization with soluble S. venezuelensis antigen associated with complete Freund's adjuvant followed by infection with S. venezuelensis protected mice from diabetes development induced by streptozotocin. Protection was characterized by a higher body weight gain, lower glycemic levels, much less severe insulitis and preserved insulin production. Together, these results indicate that S. venezuelensis contributed to protect C57BL/6 mice against experimental diabetes induced by streptozotocin.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23523576     DOI: 10.1016/j.exppara.2013.03.007

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  7 in total

Review 1.  Therapeutic potential of helminths in autoimmune diseases: helminth-derived immune-regulators and immune balance.

Authors:  Meng Wang; Linxiang Wu; Rennan Weng; Weihong Zheng; Zhongdao Wu; Zhiyue Lv
Journal:  Parasitol Res       Date:  2017-06-29       Impact factor: 2.289

Review 2.  Helminth protection against type-1 diabetes: an insight into immunomodulatory effect of helminth-induced infection.

Authors:  Muhammad Adnan Sabir Mughal; Muhammad Kasib Khan; Zaheer Abbas; Rao Zahid Abbas; Hammad Ur Rehman Bajwa; Abdullah Khalid Chatha; Muhammad Imran; Zia Ud Din Sindhu; Asghar Abbas; Arsalan Zafar; Muhammad Nadeem
Journal:  Mol Biol Rep       Date:  2021-08-25       Impact factor: 2.316

3.  Role of mast cells in the generation of a T-helper type 2 dominated anti-helminthic immune response.

Authors:  Nathan M Ryan; Steve Oghumu
Journal:  Biosci Rep       Date:  2019-02-15       Impact factor: 3.840

Review 4.  Host-microbiota interactions shaping T-cell response and tolerance in type 1 diabetes.

Authors:  Shubhabrata Majumdar; Yong Lin; Matthew L Bettini
Journal:  Front Immunol       Date:  2022-08-18       Impact factor: 8.786

5.  BCG and BCG/DNAhsp65 vaccinations promote protective effects without deleterious consequences for experimental autoimmune encephalomyelitis.

Authors:  Sofia Fernanda Gonçalves Zorzella-Pezavento; Clara Pires Fujiara Guerino; Fernanda Chiuso-Minicucci; Thais Graziela Donegá França; Larissa Lumi Watanabe Ishikawa; Ana Paula Masson; Célio Lopes Silva; Alexandrina Sartori
Journal:  Clin Dev Immunol       Date:  2013-10-29

6.  Systemic Administration of Proteoglycan Protects BALB/c Retired Breeder Mice from Experimental Arthritis.

Authors:  Larissa Lumi Watanabe Ishikawa; Priscila Maria Colavite; Thais Fernanda de Campos Fraga-Silva; Luiza Ayumi Nishiyama Mimura; Thais Graziela Donegá França; Sofia Fernanda Gonçalves Zorzella-Pezavento; Fernanda Chiuso-Minicucci; Larissa Doddi Marcolino; Camila Marques; Maura Rosane Valerio Ikoma; Alexandrina Sartori
Journal:  J Immunol Res       Date:  2016-05-18       Impact factor: 4.818

7.  Taenia crassiceps Antigens Control Experimental Type 1 Diabetes by Inducing Alternatively Activated Macrophages.

Authors:  Arlett Espinoza-Jiménez; Roberto De Haro; Luis I Terrazas
Journal:  Mediators Inflamm       Date:  2017-11-08       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.